Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5161)	8/14/1998 6:16:00 PM
From: Bhag Karamchandani	Read Replies (1) \| Respond to of 6136

Rick: I hope you will reconsider your response to leave the thread. No doubt you contributions are most valuable - even when we may occasionally disagree. I am sure we are all mature enough to debate issues. There was as much 'long' hype (remember John W- not that I ever doubted his sincerity) and from time to time 'short' hype. Then there are the rest of us who are trying to understand AGPH fortunes. Off topic: Any views on Generex Biotechnology. According to their web site( www.generex.com) they have superior proprietary technology for oral delivery of large molecules- they are conducting PII/ PIII trials for oral delivery of Insulin to Type I diabetics, in Canada. I would really appreciate your assessment of the clinical tests reported on their web site.I wish AGPH was as open to sharing its results.